You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Fluidigm's mass cytometry and microfluidics research product sales were negatively impacted by the COVID-19 pandemic.
Mount Sinai bioinformaticians have quickly pivoted from Lyme disease research to building a reference tool for researchers pursuing COVID therapies.
The Wall Street Journal has put together maps of how SARS-CoV-2 has spread based on genetic mutations that have accrued in the virus.
The firm believes the multi-part stratification project will help further commercialization of its KidneyIntelX blood-based assay for acute and chronic kidney disease.
Two analyses indicate that SARS-CoV-2 began circulating in New York in mid-February, coming from Europe.
Researchers at Mount Sinai, NYU School of Medicine, and Weill Cornell Medicine sequenced hundreds of SARS-CoV-2 genomes from NYC patients for phylogenetic analyses.
In Nature this week: single-cell transcriptomic data to map human tissue, combined genomic and machine learning approach for non-invasive early lung cancer screening, and more.
The consortium is developing a real-time PCR test for host detection assays targeting epigenetic signatures and viral RNA for early-stage monitoring of potentially infected individuals.
In Science this week: rare NOTCH signaling pathway mutations drive many head and neck squamous cell carcinomas, and more.
Genes influencing NOTCH pathway activity were linked to head and neck squamous cell carcinoma with a mouse screen centered on genes with long tail mutations in human cases.
President Donald Trump announced the US would be leaving the World Health Organization, NBC News reports.
A study of Great Danes homes in on a genomic region linked to fearfulness.
CDC head says a new analysis indicates earlier testing wouldn't have caught viral spread, NPR reports.
In PLOS this week: gene expression and epigenetics of Indonesian populations, hookworm parasite secretome, and more.